H.R.1384 - Mainstreaming Addiction Treatment Act of 2021117th Congress (2021-2022) |
|Sponsor:||Rep. Tonko, Paul [D-NY-20] (Introduced 02/25/2021)|
|Committees:||House - Energy and Commerce; Ways and Means; Judiciary|
|Latest Action:||House - 04/28/2021 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.1384 — 117th Congress (2021-2022)All Information (Except Text)
Introduced in House (02/25/2021)
Mainstreaming Addiction Treatment Act of 2021
This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).
Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity.
The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.